🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To confirm the tolerability and safety of combined administration of ONO-79...
Status
Active Not Recruiting
Location
Fujita Health University Hospital
Start Date
2021-09-23
Trial ID
NCT06540261
Treatments Being Tested
In their "Magrolimab" research project, the investigators want to find out ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06-21
Trial ID
NCT05738161
Treatments Being Tested
Children and adults with recurrent or progressive malignant brain tumors ha...
Status
Completed
Location
University of California, San Francisco
Start Date
2022-04-22
Trial ID
NCT05169944
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of magrolim...
Status
Terminated
Location
University of Alabama Birmingham
Start Date
2020-09-09
Trial ID
NCT04313881
Treatments Being Tested
This Phase Ib study is designed to evaluate the safety and pharmacokinetics...
Status
Terminated
Location
UC Davis Comprehensive Cancer Center
Start Date
2019-10-08
Trial ID
NCT03922477
Treatments Being Tested
This study is to determine the safety and preliminary efficacy of sabatolim...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12-20
Trial ID
NCT05367401
Treatments Being Tested
The primary purpose of the study is to evaluate the preliminary safety and ...
Status
Terminated
Location
Yale University
Start Date
2023-06-27
Trial ID
NCT05835011
Treatments Being Tested
The goal of this clinical study is to compare the study drugs, magrolimab +...
Status
Terminated
Location
University of Arkansas for Medical Sciences
Start Date
2022-07-07
Trial ID
NCT05079230
Treatments Being Tested
Use of magrolimab in combination with standard intensive chemotherapy ("7+3...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-03-31
Trial ID
NCT05829434
Treatments Being Tested
This phase Ib/II trial identifies the best dose and possible benefits and/o...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-04-06
Trial ID
NCT04541017